Skip to main content
BMC Medical Co., Ltd. logo

BMC Medical Co., Ltd. — Investor Relations & Filings

Ticker · 301367 ISIN · CNE100005WQ4 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 528 across all filing types
Latest filing 2026-04-22 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 301367

About BMC Medical Co., Ltd.

https://www.bmc-medical.com

BMC Medical Co., Ltd. specializes in the development and distribution of diagnostic and therapeutic solutions for sleep-disordered breathing and chronic respiratory conditions. The company’s core product portfolio includes continuous positive airway pressure (CPAP) devices, bilevel positive airway pressure (BPAP) systems, and high-flow oxygen therapy equipment. These are complemented by a range of patient interfaces, including nasal, pillow, and full-face masks. BMC integrates digital health capabilities through cloud-based management platforms, enabling remote data analysis and patient monitoring. By focusing on technical innovation and clinical efficacy, the company provides integrated respiratory care systems designed to improve patient compliance and therapeutic outcomes for conditions such as obstructive sleep apnea and chronic obstructive pulmonary disease.

Recent filings

Filing Released Lang Actions
关于续聘会计师事务所的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the company's decision to reappoint an accounting firm (auditor) for the fiscal year 2026. It details the auditor's qualifications, independence, past litigation, and the approval process by the board and audit committee. The document does not contain any financial statements or audit results itself, but rather informs shareholders and the public about the intention to continue the auditor engagement and the procedural steps taken. The document length is 3392 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this fits the category of an Audit Report / Information announcement about auditor appointment rather than the audit report itself. However, since it is an announcement about auditor reappointment and not the audit report or audit results, the best fitting category is Regulatory Filings (RNS) as a general regulatory announcement about auditor appointment, not a full audit report (AR).
2026-04-22 Chinese
2025年度独立董事述职报告（库逸轩）
Board/Management Information Classification · 95% confidence The document is titled as the "2025年度独立董事述职报告" which translates to "2025 Annual Independent Director's Work Report." It is a detailed report by an independent director about their duties, attendance, committee work, communication with auditors, and other governance-related activities during the year 2025. The content focuses on the independent director's role, oversight, and compliance with laws and company regulations. It does not contain financial statements or earnings data, nor is it an announcement or proxy material. It is a management-related report focusing on board and governance activities, specifically the independent director's report on their duties and observations. This fits best under Board/Management Information (MANG) as it relates to management and board-level reporting rather than financial results or audit reports.
2026-04-22 Chinese
关于举行2025年度网上业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about holding an online performance explanation meeting (业绩说明会) for the fiscal year 2025. It references the prior release of the 2025 Annual Report and its summary but does not contain the report itself or detailed financial data. The document invites investors to participate in a webcast Q&A session with company executives. The length is short (875 characters), and the content is clearly an announcement of an event related to discussing the annual report, not the report itself. Therefore, it fits best as an Investor Presentation (IP) since it is a detailed presentation event focusing on financial results and company performance for investors.
2026-04-22 Chinese
2025年度内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2025 年度内部控制自我评价报告' which translates to '2025 Annual Internal Control Self-Evaluation Report'. It is a detailed report on the company's internal control evaluation for the fiscal year ending December 31, 2025. The content includes descriptions of internal control environment, risk assessment, control activities, information and communication, and internal supervision. It also discusses the absence of significant internal control deficiencies and compliance with regulatory standards. The document is comprehensive and contains substantive information about internal controls rather than just an announcement or summary. This type of document fits the category of an Audit Report / Information (AR), as it focuses on internal control evaluation and audit-related information rather than a full annual report or other categories. FY 2025
2026-04-22 Chinese
关于向银行申请综合授信额度的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Beijing Ruimait Medical Technology Co., Ltd. regarding the application for a comprehensive credit line from banks, including details about the credit limit, usage, and approval process. It mentions board resolutions and the need for shareholder approval but does not contain financial statements or detailed financial data. The document is relatively short (1482 characters) and serves as a formal notice of financing activity rather than a full financial report or detailed management discussion. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2026-04-22 Chinese
北京瑞迈特医疗科技股份有限公司章程
Governance Information Classification · 95% confidence The document is a detailed company charter or articles of association for Beijing Ruimait Medical Technology Co., Ltd. It includes chapters on general provisions, business scope, shares issuance and transfer, shareholders and shareholders' meetings, board of directors, senior management, financial accounting system, profit distribution, audit, notices and announcements, mergers, splits, capital increases and decreases, dissolution and liquidation, and amendments to the articles. The content is legal and governance-related, focusing on company structure, shareholder rights, board responsibilities, and procedural rules. There is no indication of financial statements, audit opinions, earnings data, or investor presentations. It is not an announcement or a brief notice but a comprehensive governance document. Therefore, the most appropriate classification is Governance Information (CGR).
2026-04-22 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.